Purple Biotech Ltd (TLV:PPBT)
1.000
0.00 (0.00%)
May 12, 2026, 2:12 PM IDT
Purple Biotech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
18.59M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 12.28M |
| Clal Biotechnology Industries | 11.55M |
| BioLineRx | 3.76M |
| XTL Biopharmaceuticals | 3.26M |
| Can-Fite BioPharma | 1.29M |
| Geffen Residence & Renewal | 78.00K |
| BioLight Life Sciences | 21.00K |
Purple Biotech News
- 17 days ago - Purple Biotech reports IM1240 demonstrates potent anti-tumor activity - TheFly
- 7 weeks ago - Purple Biotech announces collaboration with Converge Bio - TheFly
- 2 months ago - Purple Biotech regains compliance with Nasdaq - TheFly
- 2 months ago - Purple Biotech price target lowered to $30 from $34 at H.C. Wainwright - TheFly
- 2 months ago - Purple Biotech CEO Gil Efron to step down in August - TheFly
- 2 months ago - Purple Biotech reports Q4 EPS ($19.85) vs. ($2.00) last year - TheFly
- 2 months ago - Purple Biotech Announces CEO Transition - GlobeNewsWire
- 2 months ago - Purple Biotech trading halted, news pending - TheFly